External trigeminal nerve stimulation for drug resistant epilepsy: A randomized controlled trial
Author(s) -
Francisco Gil-López,
Teresa Boget,
Isabel Manzanares,
Antonio Donaire,
Estefanía CondeBlanco,
Eva Baillés,
Luís Pintor,
Xavier Setoaín,
Núria Bargalló,
Judith NavarroOtano,
Jordi CasanovaMollá,
Josep Valls,
Pedro Roldán,
Jordi Rumià,
Georgina Casanovas,
Gema Doménech,
Ferrán Torres,
Mar Carreño
Publication year - 2020
Publication title -
brain stimulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 81
eISSN - 1935-861X
pISSN - 1876-4754
DOI - 10.1016/j.brs.2020.06.005
Subject(s) - epilepsy , mood , randomized controlled trial , drug resistant epilepsy , medicine , quality of life (healthcare) , epilepsy surgery , tolerability , anesthesia , neuropsychology , neurostimulation , trigeminal nerve , adverse effect , psychology , surgery , cognition , stimulation , clinical psychology , psychiatry , nursing
External trigeminal nerve stimulation (ETNS) is an emergent, non-invasive neurostimulation therapy delivered bilaterally with adhesive skin electrodes. In previous studies, ETNS was associated to a decrease in seizure frequency in patients with focal drug-resistant epilepsy (DRE).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom